Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fosinopril

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with fosinopril in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(fosinopril)
Trials
(fosinopril)
Recent Studies (post-2010) (fosinopril)
9,15618755243315450

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Medvedev, IN; Simonenko, VB; Tolmachev, VV1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fosinopril

ArticleYear
[Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome].
    Klinicheskaia meditsina, 2007, Volume: 85, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Hypertension; Male; Metabolic Syndrome; Platelet Activating Factor

2007